Dr. Rae Bacharach discusses the Neurology Today article, “Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com.

Show reference:

https://journals.lww.com/neurotodayonline/pages/default.aspx

https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964

In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis.

Show reference:

https://www.bmj.com/content/386/bmj-2024-080107

Drs. Justin Abbatemarco, Marius Ringelstein, and Ilya Ayzenberg discuss a new class of complement inhibitors that we're using in NMOSD.

Show reference:

https://www.neurology.org/doi/full/10.1212/WNL.0000000000209888

In part two of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss clinical pearls on how to select an acute treatment plan for migraine.

Show reference:

https://www.bmj.com/content/386/bmj-2024-080107

In the first part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani explain the significance of this study and how its findings can be applied in clinical practice.

Show reference:

https://www.bmj.com/content/386/bmj-2024-080107

Dr. Jodie Roberts and Dr. Amra Sakusic discusses the relationship between reversal therapy and ischemic stroke, between duration off anticoagulation and risk of ischemic strokes or systemic embolism.

Learn more about the Neurology Practice Current section and fill out the survey now.

Show reference:

https://survey.alchemer.com/s3/7969148/Practice-Current-When-do-you-start-anticoagulation-therapy-for-patients-with-both-ICH-and-AF

https://www.neurology.org/doi/10.1212/WNL.0000000000209664

In this Women's History Minute, Dr. Alison Christy discusses the Cajal School of Neuropathology in Spain and emphasizes the importance of mentorship.

Dr. Greg Cooper and Dr. Clifford R. Jack Jr. discuss objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research and clinical practice.

Show reference:

https://pubmed.ncbi.nlm.nih.gov/38934362/